[A new determination method of L-dopa in blood (author's transl)].
作者信息
Weitbrecht W U, Birg W, Metzel E, Mundinger F
出版信息
Med Klin. 1974 Mar 22;69(12):500-1.
PMID:4831452
Abstract
摘要
相似文献
1
[A new determination method of L-dopa in blood (author's transl)].血液中左旋多巴的一种新测定方法（作者译）
Med Klin. 1974 Mar 22;69(12):500-1.
2
[Advantages of the combination therapy (L-Dopa and decarboxylase inhibitors) in parkinsonism].
Wien Med Wochenschr. 1972 Jun 17;122(25):369-71.
3
[Therapy of parkinsonism using a combination of L-dopa and decarboxylase inhibitor].左旋多巴与脱羧酶抑制剂联合治疗帕金森病
Med Welt. 1973 Apr 27;24(17):705-7.
4
[Dopa metabolism in relation to the therapy of Parkinson's syndrome].
Actual Pharmacol (Paris). 1971;24:27-49.
5
[Effects of additional medication of Amantadine sulfate in L-dopa-pretreated patients with Parkinson's syndrome (author's transl)].
Med Klin. 1974 Mar 29;69(13):541-5.
6
[Treatment of parkinsonism with L-dopa and an L-aromatic amino acid inhibitor].
Harefuah. 1972 Nov 1;83(9):362-4.
7
[Modalities of treatment of Parkinsonian syndrome with L-dopa].
Int J Neurol. 1972;9(1):23-32.
8
Experimental evaluation of L-dopa penetration in brain.
Trans Am Neurol Assoc. 1971;96:227-9.
9
[Dopa resorption and dopamin estimation in blood of patients with Parkinson's disease (author's transl)].帕金森病患者血液中的多巴吸收与多巴胺测定（作者译）
Arch Psychiatr Nervenkr (1970). 1974;219(3):231-7. doi: 10.1007/BF00342049.
10
[Dopa and decarboxylase inhibitors in Parkinson's disease].
Ugeskr Laeger. 1974 Feb 11;136(7):377.
Zotero 插件